US-based palliative care provider Aspire Health has closed a $32m funding round led by GV, a corporate venturing subsidiary of internet and technology conglomerate Alphabet, it revealed on Monday.
Aspire supplies non-hospice care for patients dealing with serious illnesses through care practices that use specialists including physicians, nurse practitioners, nurses, social workers and chaplains. Its partners include four of the five largest health plans in the US.
The company had served 10 states and the District of Columbia up to June this year but has since expanded rapidly, entering nine new states including New York, Ohio, Michigan and Virgina. It will use the funding to continue geographic growth and the development of its services.
Brad Smith, Aspire’s co-founder and CEO, said: “We are very excited to have GV, one of the most innovative organisations in the country, as a new investor.
“Their investment will allow Aspire to continue improving the way we care for our patients, including enriching our use of innovative data analytics and technology to enhance the support our clinicians can provide patients at home.”
The round took Aspire’s total funding to $57.5m, and comes after the company closed a $15m series C round led by venture capital and private equity fund Oak HC/FT in June 2015.
BlueCross BlueShield Venture Partners, the corporate venturing vehicle for health insurance group Blue Cross and Blue Shield Association, had previously taken part in a $5.5m round in mid-2014 that included Sandbox Industries, FCA Venture Partners and Clayton Associates.